Indication
Advanced Cancer
5 registered trials testing Psilocybin, Ketamine for this indication, 3 recruiting now.
5
Registered trials
3
Recruiting
1
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 5 trials for Advanced Cancer
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Psilocybin Therapy in Advanced CancerNCT05398484 · NYU Langone Health | Recruiting | Phase 2 / Phase 3 | psilocybin | 2 |
| Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyNCT06200155 · M.D. Anderson Cancer Center | Recruiting | Phase 2 | psilocybin | 1 |
| Psilocybin in Cancer Pain StudyNCT06001749 · Yvan Beaussant, MD, MSci | Recruiting | Phase 2 | psilocybin | 1 |
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced CancerNCT06416085 · University Health Network, Toronto | Active, not recruiting | Phase 2 | psilocybin | 1 |
| Ketamine or Placebo in Patients With Major Depression and Advanced CancerNCT04471818 · Instituto Nacional de Cancerologia de Mexico | Completed | Phase 1 / Phase 2 | ketamine | 1 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.